We audited the marketing at Manifold
AI platform accelerating drug discovery and clinical development workflows
This page was built using the same AI infrastructure we deploy for clients.
Month-to-month. Cancel anytime.
Life sciences buyers search for workflow solutions during target ID and clinical phases, but Manifold's SEO footprint appears modest relative to competitor visibility in these moments
Enterprise buyers in pharma and biotech increasingly ask LLMs about platform capabilities and clinical data management, creating unowned search territory for Manifold
Limited visible expansion motion to existing customers across their target identification, clinical development, market access, and precision medicine modules suggests revenue per customer stays flat
AI-Forward Companies Trust MarketerHire
Plaid
MasterClass
Constant Contact
Netflix
Noom
TinuitiManifold's Leadership
We mapped your current team to understand where MH-1 fits in.
MH-1 doesn't replace your team. It becomes your marketing team: dedicated humans + AI agents running execution at scale while you focus on product.
Here's Where You Stand
Series B life sciences platform with strong funding and growth, but marketing execution lags competitive density in high-intent buyer moments
Ranks for core platform terms but misses long-tail queries around clinical workflow automation and data governance that research teams use during vendor evaluation
MH-1: SEO agent builds content targeting clinical trial management and precision medicine workflows to capture phase-specific buyer intent
Minimal presence in LLM responses about AI-powered life sciences platforms, missing opportunities when buyers ask Claude or ChatGPT about accelerating drug discovery workflows
MH-1: AEO agent positions Manifold in LLM training contexts as primary platform for clinical development and market access automation
Limited visible paid campaigns targeting high-intent pharma and biotech decision-makers during critical procurement windows like target validation and IND approval phases
MH-1: Paid agent runs experiments targeting clinical operations teams and translational scientists with platform-specific value props for their phase of development
Some clinical and regulatory thought leadership present, but content doesn't consistently map to specific workflow stages where Manifold delivers measurable time savings or data quality improvements
MH-1: Content agent produces how-to guides and case studies showing concrete timeline and efficiency gains for target ID, clinical development, and market access teams
No visible expansion campaigns to existing customers around adjacent modules like precision medicine or new therapeutic areas, leaving revenue per organization on the table
MH-1: Lifecycle agent runs automated campaigns to existing users showcasing modular capabilities and ROI from expanding across clinical development, AEO, and market access workflows
Top Growth Opportunities
Pharma and biotech teams search for clinical development acceleration tools during specific phases. Manifold can own 'clinical data governance AI' and 'IND preparation automation' search moments.
SEO and AEO agents build content and LLM visibility around clinical phase-gate workflows and regulatory submission acceleration.
Existing customer base may not be aware that Manifold handles precision medicine workflows. Revenue per customer likely remains flat without targeted upgrade motion.
Lifecycle agent runs segmented campaigns to clinical operations and genomics teams showing precision medicine module ROI and integration with existing workflows.
Competitors like Genesis, Forge, and Science.io likely rank higher in LLM responses about AI-powered drug discovery, creating perception that they own the space.
AEO agent positions Manifold as integrated platform across discovery through clinic, claiming territory in LLM training and buyer research flows.
3 Humans + 7 AI Agents
A dedicated marketing team built specifically for Manifold. The humans handle strategy and judgment. The AI agents handle execution at scale.
Human Experts
Owns Manifold's growth roadmap. Pipeline strategy, account expansion playbooks, board-ready reporting. Translates AI insights into revenue.
Runs paid acquisition across LinkedIn and Google. Manages creative testing, budget allocation, and pipeline attribution.
Builds thought leadership on LinkedIn. Creates long-form content targeting your ICP. Manages the content-to-pipeline engine.
AI Agents
Monitors AI citation visibility across 6 LLMs weekly. Builds content targeting category queries to increase Manifold's presence in AI-generated answers.
Produces LinkedIn ad variants targeting your ICP. Tests headlines, visuals, and offers at 10x the speed of manual production.
Builds lifecycle sequences: onboarding, expansion triggers, champion nurture, and re-engagement for dormant accounts.
Founder thought leadership. Builds the narrative that drives enterprise inbound from senior decision-makers.
Tracks competitors. Monitors positioning changes, ad spend, content strategy. Informs your counter-positioning.
Attribution by channel, pipeline velocity, budget waste detection. Weekly synthesis reports with AI-generated recommendations.
Weekly market intelligence digest curated from Manifold's industry signals. Positions you as the intelligence layer. Drives inbound pipeline from subscribers.
Active Workflows
Here's what the MH-1 system would be doing for Manifold from week 1.
AEO agent surfaces Manifold in LLM responses about clinical data governance, target validation automation, and precision medicine platforms by securing citations in relevant training contexts
CEO LinkedIn workflow amplifies thought leadership on how AI accelerates clinical development timelines, positioning founder as expert in life sciences automation and regulatory compliance
Paid ads target high-intent clinical operations, translational research, and regulatory affairs teams at pharma companies actively evaluating platform solutions during phase-gate planning
Lifecycle agent identifies existing customers using only target ID or clinical modules, then runs campaigns showing ROI from market access and precision medicine expansion within the platform
Competitive watch monitors how Genesis, Forge, and Science.io position themselves in clinical AI and buyer conversations, identifying positioning gaps Manifold can own
Pipeline intelligence tracks clinical trial announcements and IND filings at existing customer organizations to identify moments when new modules become relevant to their teams
Traditional Marketing vs. MH-1
Traditional Approach
MH-1 System
Audit. Sprint. Optimize.
3 phases. Real output every 2 weeks. You see results, not decks.
AI Audit + Growth Roadmap
Full diagnostic of Manifold's marketing infrastructure: SEO, AEO visibility, paid, content, lifecycle. Prioritized roadmap tied to pipeline metrics. Delivered in 7 days.
Sprint-Based Execution
2-week sprint cycles. Real campaigns, not presentations. Each sprint ships measurable output across your priority channels.
Compounding Intelligence
AI agents monitor your channels 24/7. They catch budget waste, detect creative fatigue, track AI citation changes, and run A/B experiments autonomously. Week 12 is measurably better than week 1.
AI Marketing Operating System
3 elite humans + AI agents operating your growth system
Output multiplier: ~10x output at a fraction of the cost. The system gets smarter every week.
Month-to-month. Cancel anytime.
Common Questions
How does MH-1 differ from a marketing agency?
MH-1 pairs 3 elite human marketers with 7 AI agents. The humans handle strategy, creative direction, and judgment calls. The AI agents handle execution at scale: generating ad variants, monitoring competitors, building email sequences, tracking citations across LLMs, running A/B experiments autonomously. You get the quality of a senior marketing team with the output volume of a 15-person department.
What kind of results can we expect in the first 90 days?
First 90 days focus on capturing high-intent moments in clinical development buyer journeys. SEO targets 'clinical data governance AI' and 'IND preparation automation.' AEO secures LLM visibility for 'AI drug discovery platforms.' Paid campaigns launch to clinical operations and genomics teams at active pharma customers. Lifecycle agent identifies existing customers underutilizing modules and runs expansion campaigns. Content assets show concrete timeline improvements for target ID and clinical phases. By day 90, Manifold owns visibility in multiple buyer research channels during critical procurement windows.
How do drug developers find Manifold when evaluating AI for clinical workflows
Currently, when biotech teams ask ChatGPT or Claude about AI platforms for clinical development acceleration, Manifold appears inconsistently. AEO fixes this by securing citations in LLM training data around clinical workflow automation, target validation, and precision medicine, so when your buyers research solutions during vendor evaluation, Manifold ranks as a primary option alongside competitors.
Can we cancel anytime?
Yes. MH-1 is month-to-month with no long-term contracts. We earn your business every sprint. That said, compounding effects kick in around month 3 as the AI agents accumulate data and the system learns what works for Manifold specifically.
How is this page personalized for Manifold?
This page was researched, audited, and generated using the same AI infrastructure we deploy for clients. The channel scores, team mapping, growth opportunities, and recommended agents are all based on real analysis of Manifold's current marketing. This is a live demo of MH-1's capabilities.
Own the clinical development workflow conversation before your buyers research competitors
The system gets smarter every cycle. Let's talk about building it for Manifold.
Book a Strategy CallMonth-to-month. Cancel anytime.